Lineage Cell Therapeutics, Inc. (LCTX)
Lineage Cell Therapeutics, Inc. is a biotechnology company focused on developing innovative regenerative therapies using pluripotent and adult-derived cell technologies. The company aims to address unmet medical needs in areas such as neurodegenerative diseases, vision loss, and oncology by advancing the development of targeted cell-based treatments.
Company News
W.P. Carey, a diversified net lease REIT, reported Q2 2025 earnings with strong revenue growth and AFFO per share, despite experiencing net income decline due to non-cash market adjustments. The company raised full-year guidance and increased quarterly dividend.
The global refrigerated warehousing market is expected to grow significantly, driven by the surge in e-commerce, particularly in the grocery and food sectors, as well as advancements in cold storage technologies and the rising demand for temperature-sensitive products.
Cold storage giant Lineage is seeking to raise up to $3.85 billion in its initial public offering on the Nasdaq Global Select Market. The real estate investment trust is backed by private equity firm Bay Grove Capital.
A more selective small-cap index has consistently outperformed the Russell 2000
The Dow Jones index closed higher by around 25 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insid...